Synergistic effect of decreased opioid activity and sleep deprivation on head-twitch response in mice.
In schizophrenia, an opioidergic understimulation and a decreased sleep duration are found. The pathogenic significance of these factors is unknown. The present study assessed the influence of the combination of the factors on serotonergic 2A (5-HT(2A)) receptors that are possibly related to psychosis development. 2,5-dimethoxy-4-iodoamphetamine (DOI)-induced head-twitch response in mice was used as a model of 5-HT(2A) receptor functioning. Mice underwent sleep deprivation and/or a blockade of opioidergic receptors with naloxone. To evaluate the involvement of 5-HT(2A) receptor in effects observed, animals were pretreated with MDL 100,907, a potent and selective antagonist of 5-HT(2A) receptor. As was found, 4h of sleep deprivation followed by administration of naloxone significantly increases the frequency of head twitches, with sleep deprivation and naloxone being ineffective alone. The action of the "sleep deprivation-opioid understimulation" combination is antagonized completely by MDL 100,907. Thus, some schizophrenia-associated factors can synergistically enhance the activity of 5-HT(2A) receptors. These results suggest the above factors being pathogenically relevant in schizophrenia.
Ionov
Ilya D
ID
Centre on Theoretical Problems in Physical and Chemical Pharmacology, Russian Academy of Sciences, Moscow, Russia. canyon1@rol.ru
D000818:Animals; D005464:Fluorobenzenes / Q000494:pharmacology; D019416:Head Movements / Q000187:drug effects / Q000502:physiology*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009292:Narcotic Antagonists / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D011897:Random Allocation; D044402:Receptor, Serotonin, 5-HT2A / Q000378:metabolism; D011957:Receptors, Opioid / Q000378:metabolism*; D012559:Schizophrenia / Q000378:metabolism; D012702:Serotonin Antagonists / Q000494:pharmacology; D012892:Sleep Deprivation / Q000378:metabolism* / Q000523:psychology
D005464:Fluorobenzenes; D009292:Narcotic Antagonists; D010880:Piperidines; D044402:Receptor, Serotonin, 5-HT2A; D011957:Receptors, Opioid; D012702:Serotonin Antagonists; C079049:volinanserin